Dear Editor,
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Primary Care DiabetesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Real-time continuous glucose monitoring improves glycemic control and reduces hypoglycemia: real-world data.Prim. Care Diabetes. 2022; 16: 786-790https://doi.org/10.1016/j.pcd.2022.09.005
Health Technology Wales, Freestyle Libre flash glucose monitoring for the management of diabetes. Available at: 〈https://healthtechnology.wales/wp-content/uploads/2021/09/GUI004-FlashGM-FINAL.pdf〉. (Accessed 3rd January 2023).
NICE, Type 1 diabetes in adults: diagnosis and management, 2022. 〈https://www.nice.org.uk/guidance/ng17/chapter/Recommendations〉. (Accessed 3rd January 2023).
NICE, Type 2 diabetes in adults: management, 2022. Available at: 〈https://www.nice.org.uk/guidance/ng28/chapter/Recommendations#blood-glucose-management〉. (Accessed 3rd January 2023).
- Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.Ann. Intern. Med. 2004; 141: 421-431https://doi.org/10.7326/0003-4819-141-6-200409210-00007
Article info
Publication history
Published online: January 13, 2023
Accepted:
January 9,
2023
Received:
January 3,
2023
Identification
Copyright
© 2023 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
